Erico Amorim de Souza Nunes receives a dose of Sinovac Biotech's Coronavac vaccine against the coronavirus disease (COVID-19), as the National Health Surveillance Agency (ANVISA) approved its use for children, in Sao Paulo, Brazil, January 20, 2022. REUTERS/Carla Carniel